Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 5Phase 4 3Phase 1 3Phase 1/2 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Hepatitis C, Chronic 2Carcinoma, Hepatocellular 2Hepatitis B, Chronic 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × peginterferon alfa-2a × Clear all
NCT03253250 2017-09-08

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Huashan Hospital

Phase 4 Unknown
432 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT00630084 2015-09-04

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase 4 Completed
120 enrolled

Neoplasms, Hepatitis C, Chronic

NCT00834860 2010-02-15

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase 4 Unknown
179 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡